Raymond James analyst Jayson Bedford lowered the price target on Abbott Labs (NYSE: ABT) to $130.00 (from $146.00) while maintaining ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE